1 year return (CAGR)
216.28%
Eterna Therapeutics Inc Exchange (NASDAQ, USD)
ERNA
4.08
-0.19 (-4.45%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-48.83%
5 year return (CAGR)
-74.17%
10 year return (CAGR)
-48.71%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
4.76M
Price/Sales
-
Ent value
2.85M
Price/Book
1.49
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-46.85%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 3.79 |
| Daily high | 4.70 |
| Daily low | 3.65 |
| Daily Volume | 523K |
| All-time high | 333750.00 |
| 1y analyst estimate | 30.00 |
| Beta | 2.62 |
| EPS (TTM) | -10.36 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| ERNA | S&P500 | |
| Current price drop from All-time high | -100.00% | -2.63% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 1 May 2026 | 9 Mar 2009 |
| Avg drop from high | -84.63% | -10.68% |
| Avg time to new high | 303 days | 12 days |
| Max time to new high | 8324 days | 1805 days |
News
